Search - tctmd.com

Displaying 101 - 120 of 197

Sort: Relevancy | Date

Presentation TCT 2014

Against the Proposal!

Presenter: John R. Laird Jr

September 14, 2014

Presentation TCT 2014

For the Proposal!

Presenter: Mehdi H. Shishehbor

September 14, 2014

Presentation TCT 2014

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Presenter: Lawrence A. Garcia, Richard M. Green, Douglas E. Drachman, Takao Ohki, MD

September 14, 2014

Presentation TCT 2014

Appropriate Use Criteria in the Periphery: Status Update

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Sahil A. Parikh

September 14, 2014

Presentation TCT 2014

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Mark H. Wholey

September 14, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

Presentation TCT 2014

The BEST and BASIL 2 Studies: Designs and Goals

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Kenneth Rosenfield

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Presentation TCT 2014

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Jihad A. Mustapha

September 14, 2014

Presentation TCT 2014

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Lanfroi Graziani

September 14, 2014

Presentation TCT 2014

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Mahmood K. Razavi

September 13, 2014

Presentation TCT 2014

Calcification in Femoropopliteal Intervention: Management Options and Outcomes

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, D. Christopher Metzger

September 13, 2014

Presentation TCT 2014

Endovascular Approaches to Common Femoral Artery Obstructive Disease: Finally Ready for Primetime?

Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Thomas Zeller

September 13, 2014

Presentation

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Presenter: Francesco Liistro

February 24, 2014

Presentation

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Presenter: Michael R. Jaff

January 20, 2014

Presentation

Is There a True Role for Endovascular Intervention for Below-Knee PAD?

Presenter: William A. Gray

December 01, 2013

Presentation TCT 2013

Role of Wound Perfusion Assessment in the Management of CLI

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Presenter: James Joye

October 28, 2013

Presentation TCT 2013

Nonsense: Get It Open, Heal the Wound, and Move On!

Presenter: Gary Ansel

October 28, 2013

Presentation TCT 2013

No Approved BTK Devices in the United States: What Does a Pivotal Device Trial with a Half-chance for Success Look Like?

Presenter: Krishna Rocha-Singh

October 28, 2013

Advertisement

Against the Proposal!

For the Proposal!

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Appropriate Use Criteria in the Periphery: Status Update

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

The BEST and BASIL 2 Studies: Designs and Goals

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

A Primer of the Pedal Circulation: Relevance to Revascularization Strategies

Is Arteriopathy Below the Knee Biologically Unique? Implications for Therapeutic Approaches

Bioresorbable Scaffolds: Status Update and Potential Role in Femoropopliteal Disease

Calcification in Femoropopliteal Intervention: Management Options and Outcomes

Endovascular Approaches to Common Femoral Artery Obstructive Disease: Finally Ready for Primetime?

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Is There a True Role for Endovascular Intervention for Below-Knee PAD?

Role of Wound Perfusion Assessment in the Management of CLI

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Nonsense: Get It Open, Heal the Wound, and Move On!

No Approved BTK Devices in the United States: What Does a Pivotal Device Trial with a Half-chance for Success Look Like?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content